NYSE:ACH Accendra Health (ACH) Stock Price, News & Analysis $0.20 -0.01 (-5.31%) As of 01:08 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About Accendra Health Stock (NYSE:ACH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Accendra Health alerts:Sign Up Key Stats Today's Range$0.19▼$0.2150-Day Range$0.21▼$1.3252-Week Range$0.19▼$5.60Volume753,638 shsAverage Volume1.20 million shsMarket Capitalization$15.35 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingReduce Company Overview Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions. Read More Accendra Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreACH MarketRank™: 2.1019404572 of 5 starsAccendra Health scored higher than 42% of companies evaluated by MarketBeat, and ranked 416th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingReduce Consensus RatingAccendra Health has received a consensus rating of Reduce. The company's average rating score is 1.60, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and 2 sell ratings.Upside PotentialAccendra Health has a consensus price target of $1.50, representing about 677.2% upside from its current price of $0.19.Amount of Analyst CoverageAccendra Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Accendra Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Accendra Health are expected to grow in the coming year, from ($0.03) to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Accendra Health is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Accendra Health is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted11.21% of the float of Accendra Health has been sold short.Short Interest Ratio / Days to CoverAccendra Health has a short interest ratio ("days to cover") of 4.88.Change versus previous monthShort interest in Accendra Health has recently decreased by 5.32%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAccendra Health does not currently pay a dividend.Dividend GrowthAccendra Health does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Accendra Health this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for ACH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added Accendra Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Accendra Health insiders have not sold or bought any company stock.Percentage Held by Insiders2.29% of the stock of Accendra Health is held by insiders.Percentage Held by InstitutionsAccendra Health has minimal institutional ownership at this time.Read more about Accendra Health's insider trading history. Receive ACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Accendra Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACH Stock News HeadlinesAccendra Health Announces Third Quarter 2026 Earnings Release Date and Conference CallOctober 22 at 5:12 PM | markets.ft.comAccendra Health Inc ACHOctober 11, 2026 | morningstar.comMThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 23 at 1:00 AM | Chaikin Analytics (Ad)Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing StandardOctober 9, 2026 | businesswire.comAccendra Health Names Kenneth Gardner-Smith As New CEOSeptember 17, 2026 | rttnews.comAccendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of GrowthSeptember 17, 2026 | finance.yahoo.comAccendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of GrowthSeptember 17, 2026 | businesswire.comAccendra Health Inc.August 22, 2026 | money.usnews.comSee More Headlines ACH Stock Analysis - Frequently Asked Questions How have ACH shares performed this year? Accendra Health's stock was trading at $2.64 on April 9, 2026. Since then, ACH stock has decreased by 92.7% and is now trading at $0.1930. How were Accendra Health's earnings last quarter? Accendra Health, Inc. (NYSE:ACH) posted its earnings results on Monday, August, 10th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.13) by $0.06. The firm earned $613.23 million during the quarter. Accendra Health had a negative trailing twelve-month return on equity of 4.02% and a negative net margin of 11.41%. Who are Accendra Health's major shareholders? Accendra Health's top institutional shareholders include Williams & Novak Wealth Management LLC (0.15%). How do I buy shares of Accendra Health? Shares of ACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/10/2026Today10/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ACH's financial health is in the Red zone, according to TradeSmith. ACH has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:ACH CIK75252 Webwww.accendrahealth.com Phone(804) 277-4304Fax804-723-7100Employees6,500Year Founded1882Price Target and Rating Average Price Target for Accendra Health$1.50 High Price Target$1.50 Low Price Target$1.50 Potential Upside/Downside+667.7%Consensus RatingReduce Rating Score (0-4)1.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($3.91) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.10 billion Net Margins-11.41% Pretax Margin-4.36% Return on Equity-4.02% Return on Assets0.70% Debt Debt-to-Equity RatioN/A Current Ratio0.41 Quick Ratio0.30 Sales & Book Value Annual Sales$2.73 billion Price / Sales0.01 Cash Flow$3.26 per share Price / Cash Flow0.06 Book Value($5.96) per share Price / Book-0.03Miscellaneous Outstanding Shares76,900,000Free Float75,144,000Market Cap$15.03 million OptionableOptionable Beta1.57 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NYSE:ACH) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accendra Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accendra Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
